assembly Bill A7509

Signed By Governor
2017-2018 Legislative Session

Relates to interchangeable biological products

download bill text pdf

Sponsored By

Current Bill Status - Signed by Governor


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed by Governor

do you support this legislation?

You must fill out the form below in order to support or oppose this bill. X

You must login or fill out the fields below for the senator to have an accurate account of the support or opposition to this bill.

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.
Use this box to enter a message to your senator.

Actions

view actions (16)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Oct 23, 2017 signed chap.357
Oct 11, 2017 delivered to governor
Jun 21, 2017 returned to assembly
passed senate
3rd reading cal.2161
substituted for s4788a
Jun 20, 2017 referred to rules
delivered to senate
passed assembly
ordered to third reading rules cal.547
rules report cal.547
reported
Jun 16, 2017 print number 7509a
Jun 16, 2017 amend (t) and recommit to rules
Jun 07, 2017 reported referred to rules
Apr 28, 2017 referred to higher education

Co-Sponsors

Multi-Sponsors

A7509 - Details

Law Section:
Education Law
Laws Affected:
Amd §§6802, 6810 & 6816-a, Ed L; amd §206, Pub Health L

A7509 - Summary

Relates to interchangeable biological products; enacts provisions relating to substitutions of biological products by pharmacists.

A7509 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7509

                       2017-2018 Regular Sessions

                          I N  A S S E M B L Y

                             April 28, 2017
                               ___________

Introduced  by  M.  of  A.  GOTTFRIED  --  read once and referred to the
  Committee on Higher Education

AN ACT to amend the education law and the public health law, in relation
  to  the  substitution  of  interchangeable  biological  products   for
  prescribed products

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 6802 of the education law is amended by adding  two
new subdivisions 27 and 28 to read as follows:
  27.  "BIOLOGICAL  PRODUCT"  MEANS  A  BIOLOGICAL PRODUCT AS DEFINED IN
SUBSECTION (I) OF SECTION 351 OF THE PUBLIC HEALTH SERVICE ACT 42 U.S.C.
SECTION 262(I).
  28. "INTERCHANGEABLE BIOLOGICAL PRODUCT" MEANS  A  BIOLOGICAL  PRODUCT
LICENSED  BY  THE UNITED STATES FOOD AND DRUG ADMINISTRATION PURSUANT TO
42 U.S.C.   SECTION 262(K)(4) AS SET FORTH  IN  THE  LATEST  EDITION  OR
SUPPLEMENT  OF  THE  UNITED STATES FOOD AND DRUG ADMINISTRATION LISTS OF
LICENSED BIOLOGICAL PRODUCTS  WITH  REFERENCE  PRODUCT  EXCLUSIVITY  AND
BIOSIMILARITY  OR  INTERCHANGEABILITY EVALUATIONS, SOMETIMES REFERRED TO
AS THE "PURPLE BOOK," OR A BIOLOGICAL PRODUCT DETERMINED BY  THE  UNITED
STATES  FOOD AND DRUG ADMINISTRATION TO BE THERAPEUTICALLY EQUIVALENT AS
SET FORTH IN THE LATEST EDITION OR SUPPLEMENT OF THE UNITED STATES  FOOD
AND  DRUG  ADMINISTRATION APPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIV-
ALENCE EVALUATIONS, SOMETIMES REFERRED TO AS THE "ORANGE BOOK."
  S 2. Paragraphs (b), (c) and (d) of subdivision 6 of section  6810  of
the  education  law, paragraph (b) as amended and paragraph (d) as added
by chapter 913 of the laws of 1986, paragraph (c) as  added  by  chapter
776 of the laws of 1977, are amended to read as follows:
  (b)  NOTWITHSTANDING  ANY OTHER PROVISION OF THIS SECTION OR ANY OTHER
LAW, WHEN AN INTERCHANGEABLE BIOLOGICAL PRODUCT IS NOT AVAILABLE AND THE
BIOLOGICAL PRODUCT ORIGINALLY PRESCRIBED IS AVAILABLE AND THE PHARMACIST
AGREES TO DISPENSE THE PRESCRIBED BIOLOGICAL PRODUCT FOR  A  PRICE  THAT

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11241-01-7

Co-Sponsors

view additional co-sponsors

Multi-Sponsors

A7509A (ACTIVE) - Details

Law Section:
Education Law
Laws Affected:
Amd §§6802, 6810 & 6816-a, Ed L; amd §206, Pub Health L

A7509A (ACTIVE) - Summary

Relates to interchangeable biological products; enacts provisions relating to substitutions of biological products by pharmacists.

A7509A (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7509--A

                       2017-2018 Regular Sessions

                          I N  A S S E M B L Y

                             April 28, 2017
                               ___________

Introduced  by  M. of A. GOTTFRIED, QUART, RAIA -- Multi-Sponsored by --
  M. of A.  ENGLEBRIGHT, JEAN-PIERRE -- read once and  referred  to  the
  Committee  on Higher Education -- reported and referred to the Commit-
  tee on Rules -- Rules  Committee  discharged,  bill  amended,  ordered
  reprinted as amended and recommitted to the Committee on Rules

AN ACT to amend the education law and the public health law, in relation
  to   the  substitution  of  interchangeable  biological  products  for
  prescribed  products;  and  providing  for  the  expiration  of   such
  provisions

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 6802 of the education law is amended by adding  two
new subdivisions 27 and 28 to read as follows:
  27.  "BIOLOGICAL  PRODUCT"  MEANS  A  BIOLOGICAL PRODUCT AS DEFINED IN
SUBSECTION (I) OF SECTION 351 OF  THE  PUBLIC  HEALTH  SERVICE  ACT,  42
U.S.C. SECTION 262(I).
  28.  "INTERCHANGEABLE  BIOLOGICAL  PRODUCT" MEANS A BIOLOGICAL PRODUCT
LICENSED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION  PURSUANT  TO
42  U.S.C.    SECTION  262(K)(4)  AS  SET FORTH IN THE LATEST EDITION OR
SUPPLEMENT OF THE UNITED STATES FOOD AND DRUG  ADMINISTRATION  LISTS  OF
LICENSED  BIOLOGICAL  PRODUCTS  WITH  REFERENCE  PRODUCT EXCLUSIVITY AND
BIOSIMILARITY OR INTERCHANGEABILITY EVALUATIONS, SOMETIMES  REFERRED  TO
AS  THE  "PURPLE BOOK," OR A BIOLOGICAL PRODUCT DETERMINED BY THE UNITED
STATES FOOD AND DRUG ADMINISTRATION TO BE THERAPEUTICALLY EQUIVALENT  AS
SET  FORTH IN THE LATEST EDITION OR SUPPLEMENT OF THE UNITED STATES FOOD
AND DRUG ADMINISTRATION APPROVED DRUG PRODUCTS WITH  THERAPEUTIC  EQUIV-
ALENCE EVALUATIONS, SOMETIMES REFERRED TO AS THE "ORANGE BOOK."
  S  2.  Paragraphs (b), (c) and (d) of subdivision 6 of section 6810 of
the education law, paragraph (b) as amended and paragraph (d)  as  added
by  chapter  913  of the laws of 1986, paragraph (c) as added by chapter
776 of the laws of 1977, are amended to read as follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11241-02-7

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.